These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 30895352)

  • 1. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage.
    Zeng L; Huang W; Cao Z; Zheng B; Liu X; Guo L; Feng X
    Ann Hematol; 2019 Jun; 98(6):1467-1476. PubMed ID: 30895352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
    Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
    Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CD16 expression is an independent prognostic factor for extranodal NK/T cell lymphoma of nasal type].
    Zuo Z; Yang QP; Tang Y; Zhao S; Yu JB; Liu YM; Gao LM; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):227-33. PubMed ID: 23928528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the clinicopathological features and prognosis in patients with extranodal natural killer/T cell lymphoma.
    Zeng LS; Huang WT; Qiu T; Shan L; Guo L; Ying JM; Lyu N; Feng XL
    Chronic Dis Transl Med; 2017 Dec; 3(4):252-259. PubMed ID: 29354808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Expression of Prohibitin Is Related to Prognosis of Nasal Extranodal Natural Killer/T Cell Lymphoma, Nasal Type.
    Guo WW; Chen LH; Yin W; Mo LX
    Oncol Res Treat; 2020; 43(10):491-497. PubMed ID: 32756049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
    Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
    Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
    Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ
    Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of PDGFRA and CMYC in extranodal NK/T-cell lymphoma and their prognostic implications].
    Chen YP; Zhu WF; Lin JY; He TM; Ma HM; Lu JP; Ye XA; Xu CW; Chen G
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):825-830. PubMed ID: 28056296
    [No Abstract]   [Full Text] [Related]  

  • 10. [Expression of mTOR and 4E-BP1 in extranodal Nasal-type NK/T-cell Lymphoma and implication for prognosis].
    Zhang Q; Liu G; Hang W
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):123-127. PubMed ID: 30808136
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel prognostic model based on ferritin and nomogram-revised risk index could better stratify patients with extranodal natural killer/T-cell lymphoma.
    Liu X; Liang Y; Shen Z; Wei L; Yang J; Piao Y; Sang W; Li P; Wang L
    Cancer Med; 2023 May; 12(9):10660-10671. PubMed ID: 36924334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and Prognosis of Newly Diagnosed Advanced-Stage Extranodal Natural Killer/T-Cell Lymphoma: A Single-Center Real-World Study across Two Decades.
    Wei YC; Qi F; Chen B; Zhang CG; Fang H; Zhang D; Qi SN; Chai Y; Li YX; Dong M
    Chemotherapy; 2024; 69(2):108-121. PubMed ID: 37984344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and significance of Ku80 and PDGFR-α in nasal NK/T-cell lymphoma.
    Li J; Chen P; Liu W; Xia Z; Shi F; Zhong M
    Pathol Res Pract; 2016 Mar; 212(3):204-9. PubMed ID: 26778387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study.
    Wei YC; Liu WX; Qi F; Zhang CG; Zheng BM; Xie Y; Chen B; Zhang D; Liu WP; Fang H; Chai Y; Qi SN; Li YX; Wang WH; Song YQ; Zhu J; Dong M
    Ann Hematol; 2024 Jan; 103(1):163-174. PubMed ID: 37817010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.
    Wu X; Li P; Zhao J; Yang X; Wang F; Yang YQ; Fang F; Xu Y; Zhang H; Wang WY; Yi C
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):619-25. PubMed ID: 18790372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
    Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
    Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of pSTAT3 and PD-L1 in extranodal NK/T cell lymphoma and its clinical significance].
    Zhang F; Luo DL; Chen Y; Yan JH; Luo LQ; Liu J; Liu YH
    Zhonghua Bing Li Xue Za Zhi; 2020 Oct; 49(10):999-1002. PubMed ID: 32992412
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of Skp2 in extranodal NK/T-cell lymphoma.
    Guo HQ; Pu XX; Guo CC; Rao HL; Li HR; Lin TY
    Chin J Cancer; 2010 May; 29(5):567-71. PubMed ID: 20426910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
    Yamaguchi M; Tobinai K; Oguchi M; Ishizuka N; Kobayashi Y; Isobe Y; Ishizawa K; Maseki N; Itoh K; Usui N; Wasada I; Kinoshita T; Ohshima K; Matsuno Y; Terauchi T; Nawano S; Ishikura S; Kagami Y; Hotta T; Oshimi K
    J Clin Oncol; 2009 Nov; 27(33):5594-600. PubMed ID: 19805668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of sequence of radiotherapy and chemotherapy on prognosis of patients with early-stage extranodal NK/T cell lymphoma (nasal type) and its individualized application].
    Yang J; Yang Y; Qi SN; Wu T; He X; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Qiao XY; Wang H; Li GF; Zhu Y; Cao JZ; Wu JX; Zhu SY; Shi M; Su H; Zhang XM; Zhang HL; Huang HQ; Zhang YJ; Song YQ; Zhu J; Wang Y; Li YX
    Zhonghua Yi Xue Za Zhi; 2021 May; 101(17):1232-1238. PubMed ID: 34865391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.